Archive for the ‘news’ Category
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro™ to Desitin Pharmaceuticals, GmbH
Monday, March 17th, 2008
Zogenix Raises $18 Million in Preferred Stock Financing
Wednesday, January 9th, 2008
Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Tuesday, November 27th, 2007
Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
Thursday, June 7th, 2007
Zogenix Closes $10 Million Deal with GE Healthcare Financial Services
Monday, March 19th, 2007
Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Sunday, October 15th, 2006
Zogenix, Inc. Names Founding Management Team
Monday, August 28th, 2006
Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors
Monday, August 28th, 2006
Zogenix Licenses European Development and Commercial Rights for sumatriptan DosePro™ to Desitin Pharmaceuticals, GmbH
Monday, March 17th, 2008Zogenix Raises $18 Million in Preferred Stock Financing
Wednesday, January 9th, 2008Zogenix Licenses Exclusive U.S. Commercial Rights for Late Stage, Controlled-Release, Opioid Product from Elan
Tuesday, November 27th, 2007Zogenix Appoints David Nassif Executive Vice President and Chief Financial Officer
Thursday, June 7th, 2007Zogenix Closes $10 Million Deal with GE Healthcare Financial Services
Monday, March 19th, 2007Zogenix Appoints J.D. Haldeman Vice President, Commercial Strategy & Corporate Communications
Sunday, October 15th, 2006Zogenix, Inc. Names Founding Management Team
Monday, August 28th, 2006Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors
Monday, August 28th, 2006